const { PrismaClient } = require("@prisma/client");
const bcrypt = require("bcryptjs");

const prisma = new PrismaClient();

async function main() {
  console.log("🌱 Seeding database...");

  // 1. Clear existing seed data if any (idempotent)
  await prisma.post.deleteMany();
  await prisma.category.deleteMany();
  await prisma.tag.deleteMany();
  await prisma.author.deleteMany();
  await prisma.user.deleteMany();
  await prisma.page.deleteMany();
  await prisma.siteSetting.deleteMany();
  await prisma.subscriber.deleteMany();
  await prisma.contactMessage.deleteMany();

  // 2. Create Admin & Editor Users
  const passwordHash = await bcrypt.hash("AdminPass123!", 10);
  const adminUser = await prisma.user.create({
    data: {
      name: "Mr. KD",
      email: "admin@sitename.com",
      passwordHash,
      role: "ADMIN",
      avatar: "https://images.unsplash.com/photo-1534528741775-53994a69daeb?auto=format&fit=crop&w=400&q=80",
      bio: "Chief Editor and Administrator passionate about health technology, science, and wellness publishing.",
    },
  });

  const editorHash = await bcrypt.hash("EditorPass123!", 10);
  await prisma.user.create({
    data: {
      name: "Marcus Chen",
      email: "editor@sitename.com",
      passwordHash: editorHash,
      role: "EDITOR",
      avatar: "https://images.unsplash.com/photo-1622253692010-333f2da6031d?auto=format&fit=crop&w=400&q=80",
      bio: "Senior Technology Editor covering biomedical engineering and computational medicine.",
    },
  });

  // 3. Create 3 Demo Authors (High E-E-A-T credentials)
  const author1 = await prisma.author.create({
    data: {
      name: "Dr. Sarah Jenkins, MD, FACC",
      slug: "dr-sarah-jenkins",
      credentials: "MD, FACC - Board Certified Cardiologist",
      title: "Attending Cardiologist & Clinical Associate Professor",
      bio: "Dr. Sarah Jenkins is an attending cardiologist and clinical researcher specializing in preventive cardiovascular medicine, hemodynamic monitoring, and metabolic syndrome. She holds a medical degree from Johns Hopkins University School of Medicine and completed her fellowship at Brigham and Women's Hospital.",
      avatar: "https://images.unsplash.com/photo-1559839734-2b71ea197ec2?auto=format&fit=crop&w=400&q=80",
      email: "s.jenkins@sitename.com",
      socialTwitter: "https://twitter.com/DrJenkinsHeart",
      socialLinkedin: "https://linkedin.com/in/sarahjenkins-md",
    },
  });

  const author2 = await prisma.author.create({
    data: {
      name: "Dr. Marcus Chen, PhD",
      slug: "dr-marcus-chen",
      credentials: "PhD in Biomedical Engineering & Computational Biology",
      title: "Biomedical Systems Researcher & Health Tech Strategist",
      bio: "Dr. Marcus Chen earned his doctorate from MIT and specializes in computational diagnostics, machine learning architectures for biomedical imaging, and wearable sensor telemetry. He serves on international digital health advisory panels.",
      avatar: "https://images.unsplash.com/photo-1622253692010-333f2da6031d?auto=format&fit=crop&w=400&q=80",
      email: "m.chen@sitename.com",
      socialTwitter: "https://twitter.com/MarcusChenPhD",
      socialLinkedin: "https://linkedin.com/in/marcuschen-bioeng",
    },
  });

  const author3 = await prisma.author.create({
    data: {
      name: "Dr. Elena Rostova, PharmD, BCPS",
      slug: "dr-elena-rostova",
      credentials: "PharmD, BCPS - Board Certified Pharmacotherapy Specialist",
      title: "Clinical Pharmacologist & Precision Therapeutics Specialist",
      bio: "Dr. Elena Rostova is a clinical pharmacotherapy specialist with over 14 years of clinical experience in oncology therapeutics, targeted biologic agents, and gut microbiome pharmacodynamics. She consults for clinical research consortiums.",
      avatar: "https://images.unsplash.com/photo-1594824813508-620a28f74a38?auto=format&fit=crop&w=400&q=80",
      email: "e.rostova@sitename.com",
      socialTwitter: "https://twitter.com/ElenaRostovaPharmD",
      socialLinkedin: "https://linkedin.com/in/elenarostova-pharmd",
    },
  });

  // 4. Create 6 Core Categories
  const catInnovation = await prisma.category.create({
    data: {
      name: "Healthcare Innovation",
      slug: "healthcare-innovation",
      description: "Breakthrough clinical therapies, molecular biology advances, and futuristic healthcare delivery systems.",
      color: "#0d9488",
      order: 1,
    },
  });

  const catMedTech = await prisma.category.create({
    data: {
      name: "Medical Technology",
      slug: "medical-technology",
      description: "Artificial intelligence, surgical robotics, telemedicine platforms, and advanced diagnostic hardware.",
      color: "#0284c7",
      order: 2,
    },
  });

  const catWellness = await prisma.category.create({
    data: {
      name: "Wellness",
      slug: "wellness",
      description: "Evidence-based lifestyle optimization, circadian rhythms, stress resilience, and restorative health.",
      color: "#059669",
      order: 3,
    },
  });

  const catNutrition = await prisma.category.create({
    data: {
      name: "Nutrition",
      slug: "nutrition",
      description: "Clinical nutrition science, metabolic health, gut microbiome biochemistry, and macronutrient strategies.",
      color: "#d97706",
      order: 4,
    },
  });

  const catMentalHealth = await prisma.category.create({
    data: {
      name: "Mental Health",
      slug: "mental-health",
      description: "Neurobiology, clinical psychiatric interventions, cognitive behavioral frameworks, and neuroplasticity.",
      color: "#7c3aed",
      order: 5,
    },
  });

  const catPublicHealth = await prisma.category.create({
    data: {
      name: "Public Health",
      slug: "public-health",
      description: "Epidemiological surveillance, antimicrobial resistance, preventative immunization, and health policy.",
      color: "#e11d48",
      order: 6,
    },
  });

  // 5. Create Sample Tags
  const tagAI = await prisma.tag.create({ data: { name: "Artificial Intelligence", slug: "artificial-intelligence" } });
  const tagClinical = await prisma.tag.create({ data: { name: "Clinical Practice", slug: "clinical-practice" } });
  const tagGenomics = await prisma.tag.create({ data: { name: "Genomics", slug: "genomics" } });
  const tagMetabolic = await prisma.tag.create({ data: { name: "Metabolic Health", slug: "metabolic-health" } });
  const tagCardiology = await prisma.tag.create({ data: { name: "Cardiology", slug: "cardiology" } });
  const tagPharmacology = await prisma.tag.create({ data: { name: "Pharmacology", slug: "pharmacology" } });
  const tagMicrobiome = await prisma.tag.create({ data: { name: "Microbiome", slug: "microbiome" } });
  const tagNeurology = await prisma.tag.create({ data: { name: "Neurology", slug: "neurology" } });

  // 6. Seed 8 Comprehensive 600+ Word Evidence-Based Medical Articles
  console.log("Writing 8 rich medical articles...");

  // Post 1: Clinical AI
  await prisma.post.create({
    data: {
      title: "Beyond the Hype: The Clinical Reality and Biomedical Impact of Artificial Intelligence in Modern Healthcare",
      slug: "role-of-ai-in-healthcare",
      excerpt: "An in-depth, evidence-based exploration of artificial intelligence in clinical workflows, covering diagnostic computer vision, predictive EHR analytics, structural pharmacology, and FDA regulatory frameworks.",
      content: `
<p>The integration of Artificial Intelligence (AI) into medicine has shifted decisively from speculative benchtop experimentation to validated clinical deployment. While early discourse oscillated between ungrounded utopian promises of autonomous physicians and dismissive skepticism, the contemporary biomedical landscape recognizes AI as a multifaceted suite of algorithmic tools designed to optimize diagnostic precision, triage urgent pathologies, decipher complex macromolecules, and mitigate administrative cognitive load. Moving past superficial buzzwords requires analyzing the specific biological, clinical, and regulatory mechanisms driving AI adoption across modern health systems.</p>

<h2>1. Diagnostic Computer Vision: From Pattern Matching to Quantitative Phenotyping</h2>
<p>Medical imaging represents the most mature clinical domain for machine learning translation. Historically, radiologic and histopathologic interpretations have been qualitative and subjective, constrained by human perceptual thresholds and fatigue. Deep convolutional neural networks (CNNs) and emergent Vision Transformers (ViTs) process raw pixel matrices into quantitative spatial feature vectors, enabling sub-visual pattern extraction.</p>
<p>In screening mammography and low-dose chest computed tomography (LDCT), FDA-cleared AI algorithms function as autonomous second readers. In peer-reviewed prospective evaluations published in <em>Nature</em>, deep learning systems matching or marginally outperforming expert radiologists reduced both false-positive recalls and false-negative misdiagnoses in breast cancer screening cohorts. Crucially, in acute triage—such as identifying large vessel occlusions (LVO) in acute ischemic stroke or non-contrast CT detection of intracranial hemorrhage—deep learning algorithms analyze imaging scans within minutes of acquisition, instantly alerting neuro-interventional teams before a formal radiology dictation is logged.</p>

<h3>Digital Pathology and Morphometric Biomarkers</h3>
<p>In oncology, computational pathology software dissects gigapixel Whole Slide Images (WSIs). Algorithms quantify tumor-infiltrating lymphocytes (TILs), segment histologic margins, and predict genetic aberrations (such as microsatellite instability or <em>EGFR</em> mutations in lung adenocarcinoma) directly from hematoxylin and eosin (H&amp;E) stains, bypassing days of costly preliminary immunohistochemistry.</p>

<h2>2. Predictive Analytics in Electronic Health Records: Navigating Inpatient Deterioration</h2>
<p>Beyond isolated diagnostic images, modern healthcare facilities are dense repositories of longitudinal physiological data. Within intensive care units (ICUs) and general medical floors, machine learning models continuously parse time-series telemetry, hemodynamic variables, medication administrations, and laboratory outputs to anticipate clinical deterioration before manifest decompensation occurs.</p>
<p>A prime example is the early detection of sepsis—a dysregulated host response to infection with high mortality. Traditional scoring mechanisms, such as the Systemic Inflammatory Response Syndrome (SIRS) or the Sequential Organ Failure Assessment (SOFA), often exhibit low specificity, triggering alert fatigue among nursing staff. Gradient-boosted decision trees and recurrent temporal architectures evaluate non-linear interactions across vitals (e.g., subtle elevations in respiratory rate concurrent with downward trends in end-tidal CO<sub>2</sub> and platelet counts), surfacing actionable risk scores hours before overt septic shock manifests.</p>
<p>However, translation to bedside care demands vigilance. As documented in publications by the <em>Journal of the American Medical Association (JAMA)</em>, proprietary clinical predictive models frequently suffer from external validation degradation when deployed outside their derivation cohorts. Variations in hospital documentation habits, demographic shifts, and local standard-of-care practices can degrade predictive power, highlighting the urgent need for continuous local model calibration.</p>

<h2>3. Structural Biology and Accelerated Pharmacotherapy</h2>
<p>The utility of artificial intelligence extends upstream into biomedical discovery and structural biology. Historically, resolving the three-dimensional tertiary structure of proteins required years of laborious X-ray crystallography or cryo-electron microscopy (cryo-EM). Deep learning architectures—most notably DeepMind’s AlphaFold—have solved this half-century-old grand challenge in computational biology by accurately predicting protein coordinates from primary amino acid sequences alone.</p>
<p>This structural revolution drastically accelerates early-stage drug discovery:</p>
<ul>
  <li><strong>Target De-risking:</strong> Mapping previously uncharacterized orphan receptors and viral envelope conformations.</li>
  <li><strong>Generative Small-Molecule Design:</strong> Using diffusion models and reinforcement learning to synthesize de novo molecular ligands with optimal binding affinities, synthetic accessibility scores, and favorable absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles.</li>
  <li><strong>Antibody Optimization:</strong> Redesigning complementarity-determining regions (CDRs) to maximize epitope engagement while minimizing off-target immunogenicity.</li>
</ul>

<h2>4. Regulatory Safeguards, Algorithmic Bias, and SaMD Governance</h2>
<p>For an AI tool to transition into a clinical reality, it must clear rigorous regulatory oversight. The United States Food and Drug Administration (FDA) classifies medical algorithmic software under the framework of <strong>Software as a Medical Device (SaMD)</strong>, with hundreds of models granted 510(k) clearance or De Novo authorization. Yet significant clinical and ethical challenges remain:</p>
<h3>Training Distribution Shift and Demographic Disparities</h3>
<p>Machine learning models reflect the biases inherent in their training registries. An algorithm trained predominantly on dermatologic images of Fitzpatrick skin types I and II will experience severe performance decay when screening melanoma across darker skin phototypes. Mitigating these disparities requires heterogeneous, multi-institutional clinical trial validation cohorts.</p>
<h3>Algorithmic Transparency and Explainability</h3>
<p>Deep neural networks operate as high-dimensional non-linear mapping functions, often labeled as "black boxes." When an algorithm recommends withholding an intervention or flags high readmission risk, clinicians require interpretable rationales—such as attention weightings or SHAP values—to integrate algorithmic outputs into ethical bedside decision-making.</p>

<h2>5. The Clinician-in-the-Loop Paradigm</h2>
<p>The prevailing consensus across clinical societies—including the American Medical Association (AMA) and the European Society of Radiology—is that artificial intelligence will not replace clinicians; rather, clinicians who leverage AI will replace those who do not. The ultimate role of medical AI is cognitive augmentation. Ambient clinical intelligence systems transcribe doctor-patient dialogues into structured SOAP notes, returning valuable hours of direct patient engagement to overburdened physicians.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Medical professional examining clinical diagnostic imaging alongside computerized radiological analytics on a high-resolution display",
      status: "PUBLISHED",
      publishedAt: new Date("2026-02-15T09:00:00Z"),
      readingTime: 6,
      viewsCount: 1420,
      isFeatured: true,
      authorId: author2.id,
      reviewedById: author1.id,
      metaTitle: "AI in Healthcare: Clinical Reality and Diagnostic Impact",
      metaDescription: "Comprehensive evidence-based analysis of artificial intelligence in clinical workflows, radiology triage, sepsis prediction, and structural drug discovery.",
      sources: JSON.stringify([
        { title: "International evaluation of an AI system for breast cancer screening", url: "https://www.nature.com/articles/s41586-019-1799-6", citation: "McKinney, S. M., et al. (2020). Nature, 577(7788), 89–94." },
        { title: "External Validation of a Widely Implemented Proprietary Sepsis Prediction Model in Hospitalized Patients", url: "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2781307", citation: "Wong, A., et al. (2021). JAMA Internal Medicine, 181(8), 1065–1070." },
        { title: "Highly accurate protein structure prediction with AlphaFold", url: "https://www.nature.com/articles/s41586-021-03819-2", citation: "Jumper, J., et al. (2021). Nature, 596(7873), 583–589." },
        { title: "Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices", url: "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices", citation: "U.S. FDA Official SaMD Guidelines (2023)." },
      ]),
      categories: { connect: [{ id: catMedTech.id }, { id: catInnovation.id }] },
      tags: { connect: [{ id: tagAI.id }, { id: tagClinical.id }] },
    },
  });

  // Post 2: mRNA Therapeutics in Oncology
  await prisma.post.create({
    data: {
      title: "The Next Era of Precision Oncology: mRNA Vaccines and Personalized Cellular Immunotherapy",
      slug: "precision-oncology-mrna-cellular-immunotherapy",
      excerpt: "Exploring personalized neoantigen mRNA vaccines and next-generation CAR-T cell engineering in refractory solid malignancies.",
      content: `
<p>The therapeutic validation of messenger RNA (mRNA) platforms during the global coronavirus pandemic was not merely an isolated triumph of infectious disease immunology; it established an industrial foundation for personalized oncology. Today, therapeutic oncology is witnessing a monumental paradigm shift: transitioning from non-specific cytotoxic chemotherapies and broad checkpoint inhibitors toward tailored, neoantigen-targeted mRNA vaccines manufactured individually for each patient's genomic profile.</p>

<h2>1. The Neoantigen Landscape and High-Throughput Sequencing</h2>
<p>Cancers develop through progressive somatic DNA mutations. Many non-synonymous mutations generate novel peptide sequences that are absent from normal tissues—termed <strong>neoantigens</strong>. Because host T-cell repertoires are not tolerized to these foreign neoepitopes, they constitute pristine immunological targets for cytotoxic CD8+ T-cell attack.</p>
<p>The manufacturing workflow for a personalized mRNA cancer vaccine represents a remarkable marriage of molecular genomics, bioinformatics, and lipid nanoparticle (LNP) chemistry:</p>
<ol>
  <li><strong>Tumor Resection &amp; Normal Tissue Biopsy:</strong> High-throughput next-generation sequencing (NGS) performs whole-exome sequencing (WES) and RNA sequencing (RNA-seq) on both tumor tissue and peripheral blood mononuclear cells (PBMCs).</li>
  <li><strong>In Silico Neoantigen Prediction:</strong> Machine learning algorithms (such as NetMHCpan) predict peptide-MHC binding affinities and quantify which mutant peptides will be effectively processed, presented on patient-specific HLA complexes, and recognized by the T-cell receptor (TCR).</li>
  <li><strong>mRNA Synthesis &amp; Microfluidic Encapsulation:</strong> Up to 34 patient-specific neoantigen sequences are transcribed into modified synthetic mRNA, encased inside ionizable lipid nanoparticles designed for targeted uptake by splenic dendritic cells.</li>
</ol>

<h2>2. Clinical Trial Evidence in High-Risk Melanoma and Pancreatic Ductal Adenocarcinoma</h2>
<p>Recent phase 2b randomized trial data published in <em>The Lancet</em> evaluating adjuvant individualized neoantigen therapy (mRNA-4157/V940) combined with pembrolizumab in patients with resected high-risk melanoma demonstrated a statistically significant 44% reduction in the risk of recurrence or death compared to pembrolizumab monotherapy. Crucially, circulating tumor DNA (ctDNA) analyses demonstrated durable clearance in vaccinated cohorts.</p>
<p>Even more compelling are findings in traditionally "cold" immunogenic tumors, such as pancreatic ductal adenocarcinoma (PDAC). In pioneering studies led by investigators at Memorial Sloan Kettering Cancer Center and published in <em>Nature</em>, half of the treated PDAC patients mounted vigorous polyfunctional de novo neoantigen-specific T-cell responses that correlated with prolonged recurrence-free survival spanning over three years.</p>

<h2>3. Overcoming Immunosuppressive Tumor Microenvironments</h2>
<p>While neoantigen vaccination primes high-avidity T cells, their clinical efficacy hinges upon penetrating dense, immunosuppressive tumor stroma. Solid tumors actively suppress immune infiltration through regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and transforming growth factor-beta (TGF-β) secretion.</p>
<p>Next-generation combinatorial protocols unite mRNA vaccination with bispecific T-cell engagers (BiTEs) and local cytokine remodeling to convert immunological "cold" tumors into actively inflamed "hot" lesions receptive to checkpoint blockade.</p>

<h2>4. Clinical Considerations and Future Horizons</h2>
<p>Despite thrilling preliminary survival curves, broader implementation faces notable logistical hurdles: turnaround time (currently 6 to 9 weeks from biopsy to injection) must be compressed to accommodate patients with aggressive disease kinetics. As synthetic biology, automated microfluidics, and predictive immunological modeling converge, personalized mRNA therapeutics promise to revolutionize long-term cancer remission.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1532187863486-abf9dbad1b69?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Laboratory scientist holding specialized micropipette over biological assay plate researching cellular mRNA therapies",
      status: "PUBLISHED",
      publishedAt: new Date("2026-02-12T14:30:00Z"),
      readingTime: 7,
      viewsCount: 980,
      isFeatured: false,
      authorId: author3.id,
      reviewedById: author1.id,
      metaTitle: "Personalized mRNA Vaccines in Oncology: Clinical Advances",
      metaDescription: "Evidence-based overview of neoantigen mRNA cancer vaccines, clinical trial outcomes in melanoma and pancreatic cancer, and combination immunotherapy.",
      sources: JSON.stringify([
        { title: "A personalized neoantigen vaccine for pancreatic cancer", url: "https://www.nature.com/articles/s41586-023-06059-3", citation: "Rojas, L. A., et al. (2023). Nature, 618(7963), 144–150." },
        { title: "Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab in resected melanoma", url: "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02268-7/fulltext", citation: "Weber, J. S., et al. (2024). The Lancet, 403(10427), 632–644." },
        { title: "Principles and mechanisms of non-viral mRNA delivery", url: "https://www.nature.com/articles/s41578-021-00358-0", citation: "Hou, X., et al. (2021). Nature Reviews Materials, 6(12), 1078–1094." },
      ]),
      categories: { connect: [{ id: catInnovation.id }] },
      tags: { connect: [{ id: tagGenomics.id }, { id: tagPharmacology.id }] },
    },
  });

  // Post 3: Microbiome-Gut-Brain Axis
  await prisma.post.create({
    data: {
      title: "The Microbiome-Gut-Brain Axis: Neurochemical Pathways, Clinical Mood Disorders, and Dietary Interventions",
      slug: "microbiome-gut-brain-axis-neurochemistry-mood",
      excerpt: "A deep dive into bidirectional vagal signaling, short-chain fatty acids (SCFAs), tryptophan metabolism, and clinical psychobiotics in affective disorders.",
      content: `
<p>The classical paradigm that the central nervous system (CNS) functions as an anatomically privileged, isolated regulatory organ has been dismantled by twenty-first-century gastroenterological and neurobiological research. Today, the <strong>gut-brain-microbiota axis</strong> is recognized as a complex, bidirectional biochemical superhighway connecting enteric microbial consortia with subcortical limbic circuits, the hypothalamic-pituitary-adrenal (HPA) stress axis, and systemic neuroinflammation.</p>

<h2>1. Anatomical and Biochemical Communication Conduits</h2>
<p>How do trillions of commensal bacteria residing within the distal colon influence emotional valence, cognitive flexibility, and neuropsychiatric vulnerability? Research demonstrates four interconnected conduits:</p>
<ul>
  <li><strong>The Vagus Nerve (Cranial Nerve X):</strong> Sensory afferent vagal fibers densely innervate the intestinal mucosa. Enteroendocrine cells (such as enterochromaffin cells) sense luminal microbial metabolites and release serotonin (5-HT) and cholecystokinin (CCK), transducing instantaneous electrical signals to the nucleus tractus solitarius in the brainstem.</li>
  <li><strong>Short-Chain Fatty Acids (SCFAs):</strong> Microbial anaerobic fermentation of dietary prebiotic fibers generates acetate, propionate, and butyrate. Butyrate serves as a potent endogenous histone deacetylase (HDAC) inhibitor, strengthening blood-brain barrier (BBB) tight junctions and upregulating brain-derived neurotrophic factor (BDNF) synthesis in hippocampal pyramidal neurons.</li>
  <li><strong>Tryptophan-Kynurenine Metabolic Partitioning:</strong> Tryptophan is the obligatory precursor for central serotonin synthesis. Under states of gut dysbiosis and elevated lipopolysaccharide (LPS) endotoxemia, indoleamine 2,3-dioxygenase (IDO-1) shunts tryptophan down the neurotoxic kynurenine pathway, generating quinolinic acid—an NMDA receptor agonist implicated in depressive symptomatology.</li>
  <li><strong>Immunological Cytokine Signaling:</strong> Disruption of the mucosal epithelial barrier ("leaky gut") permits translocation of gram-negative bacterial endotoxins, eliciting systemic elevations in interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) that activate microglial neuroinflammation.</li>
</ul>

<h2>2. Clinical Implications for Major Depressive Disorder and Anxiety</h2>
<p>Cross-sectional metagenomic sequencing cohorts consistently reveal depletion of butyrate-producing taxa—specifically <em>Faecalibacterium prausnitzii</em> and <em>Coprococcus</em>—in patients diagnosed with treatment-resistant Major Depressive Disorder (MDD). In parallel, inflammatory taxa such as <em>Eggerthella</em> and <em>Alistipes</em> exhibit relative overabundance.</p>
<p>Fecal microbiota transplantation (FMT) experiments in gnotobiotic rodent models definitively demonstrate causal directionality: transplanting fecal matter from depressed human donors into antibiotic-cleared mice reliably transfers anxiety-like exploratory phenotypes, anhedonia, and blunted hippocampal neurogenesis.</p>

<h2>3. Evidence-Based Nutritional Strategies: Psychobiotics and Prebiotics</h2>
<p>Can targeted dietary modifications alter psychiatric trajectories? Randomized controlled trials (RCTs) assessing Mediterranean dietary patterns (such as the landmark SMILES trial) documented substantial remission rates in moderate-to-severe depression compared to social support controls.</p>
<p>Specific probiotic strains—collectively classified as <em>psychobiotics</em>—such as <em>Lactobacillus rhamnosus</em> JB-1 and <em>Bifidobacterium longum</em> 1714, have demonstrated blunted cortisol reactivity during acute psychosocial stress challenges in double-blind placebo-controlled human crossover studies.</p>

<h2>4. Clinical Prudence and Future Therapeutic Horizons</h2>
<p>While the therapeutic implications are tantalizing, clinicians must exercise caution against commercial overreach. Direct-to-consumer stool microbiome kits lack validated diagnostic reference ranges, and microbial therapies must be regarded as adjunctive interventions alongside established evidence-based psychiatric pharmacotherapies and cognitive behavioral therapies.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1505576399279-565b52d4ac71?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Assortment of fresh antioxidant-rich vegetables, fermented foods, and prebiotic fibers supporting gut microbial diversity",
      status: "PUBLISHED",
      publishedAt: new Date("2026-02-10T11:15:00Z"),
      readingTime: 6,
      viewsCount: 1850,
      isFeatured: false,
      authorId: author1.id,
      reviewedById: author3.id,
      metaTitle: "Microbiome-Gut-Brain Axis: Clinical Neurobiology & Diet",
      metaDescription: "Comprehensive clinical review of gut-brain communication, short-chain fatty acids, vagal signaling, and psychobiotic nutrition in mood disorders.",
      sources: JSON.stringify([
        { title: "The gut microbiome in depression and anxiety: A systematic review", url: "https://www.sciencedirect.com/science/article/pii/S088915911930499X", citation: "Simpson, C. A., et al. (2021). Brain, Behavior, and Immunity, 83, 115–128." },
        { title: "A randomized controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)", url: "https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0791-y", citation: "Jacka, F. N., et al. (2017). BMC Medicine, 15(1), 23." },
        { title: "Microbiota-gut-brain axis: Focus on mental health and neurodevelopmental disorders", url: "https://www.nature.com/articles/s41398-020-0762-2", citation: "Cryan, J. F., et al. (2020). Translational Psychiatry, 10(1), 1–18." },
      ]),
      categories: { connect: [{ id: catNutrition.id }, { id: catMentalHealth.id }] },
      tags: { connect: [{ id: tagMicrobiome.id }, { id: tagNeurology.id }] },
    },
  });

  // Post 4: Digital Therapeutics in Hypertension
  await prisma.post.create({
    data: {
      title: "Digital Therapeutics in Chronic Disease Management: Clinical Efficacy and Reimbursement Horizons",
      slug: "digital-therapeutics-chronic-disease-management",
      excerpt: "Evaluating prescription digital therapeutics (PDTs) in hypertension, type 2 diabetes, and insomnia: regulatory benchmarks and clinical integration.",
      content: `
<p>The proliferation of mobile health applications has inundated consumer app stores with hundreds of thousands of generic wellness tools. However, a fundamentally distinct category of software has emerged within evidence-based medicine: <strong>Prescription Digital Therapeutics (PDTs)</strong>. Unlike wellness trackers, PDTs represent clinically proven, software-driven interventions delivered through smartphone interfaces, regulated by national health authorities (such as the FDA and Germany’s BfArM/DiGA framework), and requiring a formal physician prescription.</p>

<h2>1. Defining the Rigor of Software as a Drug</h2>
<p>To achieve regulatory clearance as a PDT, a software solution must adhere to the same scientific rigor demanded of pharmaceutical molecules:</p>
<ul>
  <li><strong>Prospective Randomized Controlled Trials:</strong> The intervention must be evaluated against active digital shams or standard-of-care controls in double-blind or assessor-blinded clinical trial designs.</li>
  <li><strong>Published Peer-Reviewed Endpoints:</strong> Primary endpoints must demonstrate statistically significant, clinically meaningful improvements in validated biochemical or physiological markers (e.g., reductions in systolic blood pressure or glycated hemoglobin HbA1c).</li>
  <li><strong>Good Machine Learning Practice (GMLP) &amp; Cybersecurity:</strong> Complete compliance with HIPAA/GDPR data encryption, audit trails, and human-factors usability engineering.</li>
</ul>

<h2>2. Clinical Demonstration in Essential Hypertension and Cardiometabolic Disease</h2>
<p>Hypertension affects over 1.2 billion adults globally and is the single greatest preventable risk factor for myocardial infarction, stroke, and chronic kidney disease. Despite abundant generic antihypertensive medications, less than 25% of patients maintain long-term blood pressure control due to asymptomatic presentation, therapeutic inertia, and medication non-adherence.</p>
<p>Recent multicenter trials assessing biofeedback-driven cognitive digital therapeutics integrated with Bluetooth-enabled oscillometric sphygmomanometers demonstrate substantial therapeutic benefits. By guiding patients through daily personalized resonant-frequency breathing protocols, nocturnal autonomic recovery coaching, and sodium titration modules, clinical cohorts achieved sustained reductions of 8.4 mmHg in daytime ambulatory systolic blood pressure (ASBP)—an effect size comparable to standard first-line monotherapy.</p>

<h2>3. Overcoming Reimbursement and Physician Adoption Bottlenecks</h2>
<p>Despite rigorous clinical documentation, the widespread deployment of digital therapeutics faces significant institutional friction:</p>
<ol>
  <li><strong>EHR Interoperability:</strong> Clinicians cannot navigate disparate standalone dashboards. PDT outputs must seamlessly inject discrete data fields into Epic, Cerner, and other electronic health record architectures via HL7 FHIR standards.</li>
  <li><strong>CPT Code Reimbursement:</strong> Medicare and private commercial insurers have established Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) billing codes (such as CPT 98975, 98977, 98980), establishing sustainable revenue streams for clinical practices supervising digital treatment regimens.</li>
  <li><strong>Patient Retention and Digital Equity:</strong> Sustained engagement remains an ongoing clinical challenge, necessitating personalized behavioral economic nudges and multilingual interfaces accessible to populations with varying digital health literacy.</li>
</ol>
      `,
      featuredImage: "https://images.unsplash.com/photo-1576091160550-2173dba999ef?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Patient holding smartphone displaying clinical biofeedback trends alongside digital blood pressure monitor",
      status: "PUBLISHED",
      publishedAt: new Date("2026-02-08T16:00:00Z"),
      readingTime: 6,
      viewsCount: 760,
      isFeatured: false,
      authorId: author2.id,
      reviewedById: author1.id,
      metaTitle: "Digital Therapeutics: Evidence-Based Software in Medicine",
      metaDescription: "Clinical analysis of Prescription Digital Therapeutics (PDTs), FDA clearance standards, hypertension management trials, and RTM reimbursement.",
      sources: JSON.stringify([
        { title: "Clinical evidence for prescription digital therapeutics in chronic disease", url: "https://www.nature.com/articles/s41746-020-00336-3", citation: "Dang, A., et al. (2020). npj Digital Medicine, 3(1), 130." },
        { title: "Remote therapeutic monitoring codes and clinical implementation", url: "https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.121.17387", citation: "Kario, K., et al. (2021). Hypertension, 78(4), 1140–1151." },
      ]),
      categories: { connect: [{ id: catMedTech.id }, { id: catInnovation.id }] },
      tags: { connect: [{ id: tagCardiology.id }, { id: tagClinical.id }] },
    },
  });

  // Post 5: Sleep Architecture and Longevity
  await prisma.post.create({
    data: {
      title: "Circadian Rhythm Biology and Sleep Architecture: Molecular Mechanisms of Cellular Repair and Longevity",
      slug: "circadian-biology-sleep-architecture-longevity",
      excerpt: "Analyzing the glymphatic clearance system, slow-wave delta sleep, transcription-translation feedback loops (TTFL), and cardiovascular health.",
      content: `
<p>In modern industrial societies, sleep has all too often been treated as an expendable biological tax on human productivity. However, over the past decade, profound discoveries in chronobiology—rewarded with the 2017 Nobel Prize in Physiology or Medicine—have demonstrated that sleep is not a passive resting state. It is an intensely active, highly orchestrated neurobiological phase of cellular repair, metabolic recalibration, macromolecular turnover, and immunological rejuvenation.</p>

<h2>1. The Molecular Clock: Transcription-Translation Feedback Loops (TTFL)</h2>
<p>Nearly every mammalian cell possesses an endogenous circadian clockwork mechanism governed by cell-autonomous transcription factors. The primary positive drivers—CLOCK and BMAL1—heterodimerize in the nucleus to initiate transcription of Period (<em>PER1/2/3</em>) and Cryptochrome (<em>CRY1/2</em>) genes. Over a roughly 24-hour cycle, PER and CRY proteins accumulate in the cytoplasm, translocate back into the nucleus, and bind the CLOCK-BMAL1 complex to repress their own transcription.</p>
<p>When environmental cues (zeitgebers)—such as morning sunlight exposure (stimulating intrinsically photosensitive retinal ganglion cells, ipRGCs) or late-night artificial blue light—shift these oscillations out of synchrony with the central suprachiasmatic nucleus (SCN), cellular metabolic dysregulation and DNA repair impairment ensue.</p>

<h2>2. The Glymphatic System: Waste Clearance During Slow-Wave Sleep</h2>
<p>One of the most consequential anatomical breakthroughs of recent years was the characterization of the <strong>glymphatic system</strong> by Dr. Maiken Nedergaard and colleagues. During wakefulness, dense parenchymal cellular volume prevents convective fluid flow through interstitial spaces.</p>
<p>During Non-Rapid Eye Movement (NREM) Stage 3 slow-wave sleep (delta sleep), astrocytic end-feet expressing the water channel aquaporin-4 (AQP4) allow a 60% expansion of brain interstitial space. This permits pulsed cerebrospinal fluid (CSF) to mix with interstitial fluid (ISF), washing away neurotoxic waste products accumulated during waking metabolic activity, including:</p>
<ul>
  <li><strong>Amyloid-beta (Aβ) peptides:</strong> Monomeric and oligomeric aggregates implicated in Alzheimer's pathogenesis.</li>
  <li><strong>Hyperphosphorylated Tau:</strong> Neurofibrillary tangle precursors.</li>
  <li><strong>Alpha-synuclein:</strong> Hallmarks of Lewy body pathology.</li>
</ul>

<h2>3. Cardiovascular and Endocrine Cascades of Sleep Fragmentation</h2>
<p>Even moderate sleep restriction (e.g., 5 to 6 hours per night for one week) induces pronounced endocrine aberrations:</p>
<ol>
  <li><strong>Insulin Sensitivity Degradation:</strong> Hyperinsulinemic-euglycemic clamp studies show up to a 30% reduction in peripheral insulin sensitivity—rendering otherwise healthy individuals acutely prediabetic.</li>
  <li><strong>Autonomic Dysregulation:</strong> Nocturnal blood pressure dipping (the physiological 10–20% decline in systolic pressure during sleep) is abolished, sustaining elevated sympathetic tone and endothelial vascular shear stress.</li>
  <li><strong>Appetite Hormones:</strong> Leptin (satiety hormone) drops precipitously while ghrelin (orexigenic hormone) surges, promoting craving for energy-dense carbohydrates.</li>
</ol>

<h2>4. Evidence-Based Clinical Sleep Optimization</h2>
<p>To preserve neurocognitive longevity and metabolic health, clinical sleep medicine recommends establishing regular zeitgebers: morning light exposure within 30 minutes of waking (10,000 lux or natural outdoors), complete darkness and cool ambient temperatures (65–68°F / 18–20°C) for sleep, abstinence from ethanol within 3 hours of bed, and a caffeine cutoff at least 9 hours prior to planned sleep onset.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1541781774459-bb2af2f05b55?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Serene bedroom setting emphasizing dark, quiet, sleep-supportive environmental design",
      status: "PUBLISHED",
      publishedAt: new Date("2026-02-05T08:45:00Z"),
      readingTime: 6,
      viewsCount: 1640,
      isFeatured: false,
      authorId: author1.id,
      reviewedById: author2.id,
      metaTitle: "Circadian Rhythms & Sleep Architecture: Cellular Longevity",
      metaDescription: "Evidence-based exploration of the glymphatic clearance system, molecular clock loops (CLOCK-BMAL1), and metabolic consequences of sleep restriction.",
      sources: JSON.stringify([
        { title: "The glymphatic system: A beginner's guide", url: "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636982/", citation: "Jessen, N. A., et al. (2015). Neurochemical Research, 40(12), 2583–2599." },
        { title: "Circadian rhythms and metabolism: From the molecular clock to physiology", url: "https://www.sciencedirect.com/science/article/pii/S155041311630154X", citation: "Bass, J. (2017). Cell Metabolism, 25(1), 11–22." },
        { title: "Sleep duration and cardiovascular disease: An updated systematic review", url: "https://academic.oup.com/eurheartj/article/32/12/1484/504128", citation: "Cappuccio, F. P., et al. (2011). European Heart Journal, 32(12), 1484–1492." },
      ]),
      categories: { connect: [{ id: catWellness.id }] },
      tags: { connect: [{ id: tagNeurology.id }, { id: tagCardiology.id }] },
    },
  });

  // Post 6: Metabolic Health & Insulin Resistance
  await prisma.post.create({
    data: {
      title: "Metabolic Flexibility and Insulin Resistance: Biomarkers, Mitochondrial Function, and Evidence-Based Nutrition",
      slug: "metabolic-flexibility-insulin-resistance-biomarkers",
      excerpt: "Understanding the molecular triggers of hepatic and muscular insulin resistance, ectopic lipid accumulation, and dietary interventions for metabolic optimization.",
      content: `
<p>Cardiometabolic diseases—encompassing non-alcoholic fatty liver disease (now metabolic dysfunction-associated steatohepatitis, MASH), type 2 diabetes mellitus, atherogenic dyslipidemia, and visceral obesity—represent the foremost drivers of global morbidity. At the core of these interconnected pathological entities lies a single underlying physiological derangement: the loss of <strong>metabolic flexibility</strong> and the insidious development of cellular insulin resistance.</p>

<h2>1. What is Metabolic Flexibility?</h2>
<p>Healthy human physiology is characterized by the capacity to alternate smoothly between substrate oxidation types depending on energetic availability and physiological demand. In the postprandial state following carbohydrate ingestion, elevated insulin suppresses lipolysis and promotes cellular glucose uptake and glycolytic flux. Conversely, during fasting, sustained endurance exercise, or caloric restriction, insulin levels decline, permitting hormone-sensitive lipase (HSL) to release free fatty acids for mitochondrial beta-oxidation and hepatic ketogenesis.</p>
<p>In metabolically inflexible individuals, this substrate switching mechanism is crippled: fasting fatty acid oxidation is blunted, while postprandial glucose disposal is severely compromised.</p>

<h2>2. Molecular Pathogenesis of Insulin Resistance</h2>
<p>Contrary to the simplistic view that insulin resistance stems merely from receptor downregulation, modern cellular biology demonstrates that ectopic lipid accumulation inside insulin-responsive tissues (skeletal muscle and hepatocytes) disrupts post-receptor signal transduction:</p>
<ul>
  <li><strong>Diacylglycerol (DAG) Accumulation:</strong> When adipocyte storage capacity is exceeded, excess free fatty acids spill into non-adipose tissues. Elevated intracellular DAG concentrations activate novel protein kinase C isoforms (specifically PKCθ in muscle and PKCε in liver).</li>
  <li><strong>IRS-1 Serine Phosphorylation:</strong> Activated PKC phosphorylates insulin receptor substrate 1 (IRS-1) on inhibitory serine residues rather than activating tyrosine residues, blocking downstream phosphatidylinositol 3-kinase (PI3K) and Akt signaling.</li>
  <li><strong>GLUT4 Translocation Failure:</strong> Without Akt phosphorylation of AS160, intracellular storage vesicles carrying glucose transporter 4 (GLUT4) cannot fuse with the plasma membrane, leaving extracellular glucose stranded in the circulation.</li>
</ul>

<h2>3. Beyond Fasting Glucose: Superior Clinical Biomarkers</h2>
<p>A tragic blind spot in routine preventative medicine is over-reliance on fasting plasma glucose alone. Pancreatic beta-cells compensate for progressive insulin resistance by hyper-secreting insulin for decades, keeping fasting glucose within "normal" laboratory reference ranges while hyperinsulinemia silently damages vascular endothelium.</p>
<p>Authoritative clinical guidelines advocate for more sensitive metrics:</p>
<ol>
  <li><strong>Fasting Serum Insulin &amp; HOMA-IR:</strong> The Homeostatic Model Assessment of Insulin Resistance accurately quantifies hepatic resistance years prior to HbA1c elevation.</li>
  <li><strong>Triglyceride-to-HDL Ratio:</strong> A fasting ratio above 2.0 (in mg/dL) serves as a potent clinical surrogate for small, dense LDL particle phenotypes and insulin resistance.</li>
  <li><strong>Apolipoprotein B (ApoB):</strong> Direct quantification of circulating atherogenic lipoprotein particles rather than calculated LDL cholesterol.</li>
</ol>

<h2>4. Evidence-Based Dietary Interventions</h2>
<p>Restoring insulin sensitivity requires addressing the underlying energetic over-nutrition and chronic low-grade inflammation. Substantial clinical trial evidence demonstrates that reducing refined carbohydrates, minimizing ultra-processed foods containing high-fructose corn syrup, emphasizing dietary fiber (40+ grams daily), and incorporating resistance exercise (which stimulates non-insulin-dependent GLUT4 translocation via AMPK activation) effectively reverses hepatic steatosis and restores metabolic flexibility.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1498837167922-ddd27525d352?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Wholesome Mediterranean food assortment including extra virgin olive oil, nuts, seeds, and leafy greens",
      status: "PUBLISHED",
      publishedAt: new Date("2026-02-02T13:20:00Z"),
      readingTime: 6,
      viewsCount: 1120,
      isFeatured: false,
      authorId: author1.id,
      reviewedById: author3.id,
      metaTitle: "Metabolic Flexibility & Insulin Resistance: Clinical Insights",
      metaDescription: "Clinical explanation of insulin resistance mechanisms, DAG-PKC signaling, HOMA-IR biomarkers, and evidence-based nutritional therapeutics.",
      sources: JSON.stringify([
        { title: "Mechanisms of insulin resistance: From cell to human physiology", url: "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038351/", citation: "Shulman, G. I. (2014). Physiological Reviews, 94(4), 1027–1086." },
        { title: "Metabolic flexibility in health and disease", url: "https://www.sciencedirect.com/science/article/pii/S1550413117305609", citation: "Goodpaster, B. H., & Sparks, L. M. (2017). Cell Metabolism, 26(5), 720–736." },
      ]),
      categories: { connect: [{ id: catNutrition.id }] },
      tags: { connect: [{ id: tagMetabolic.id }, { id: tagCardiology.id }] },
    },
  });

  // Post 7: Antimicrobial Resistance Crisis
  await prisma.post.create({
    data: {
      title: "The Antimicrobial Resistance Crisis: Novel Peptides, Phage Therapy, and Global Stewardship",
      slug: "antimicrobial-resistance-crisis-phage-therapy",
      excerpt: "Analyzing the silent pandemic of multidrug-resistant pathogens (ESKAPE), engineered bacteriophages, and antimicrobial peptide development.",
      content: `
<p>While acute respiratory viral outbreaks capture international headlines, the global healthcare infrastructure confronts a silent, escalating, and profoundly lethal pandemic: <strong>Antimicrobial Resistance (AMR)</strong>. A comprehensive global analysis published in <em>The Lancet</em> revealed that bacterial AMR was directly attributable to an estimated 1.27 million deaths annually, with multidrug-resistant infections contributing to over 4.95 million deaths worldwide.</p>

<h2>1. The ESKAPE Pathogens and Resistance Mechanisms</h2>
<p>The World Health Organization (WHO) has designated the "ESKAPE" group of pathogens as top priority threats due to their alarming capacity to evade conventional antimicrobial pharmacotherapy:</p>
<ul>
  <li><em>Enterococcus faecium</em> (Vancomycin-resistant, VRE)</li>
  <li><em>Staphylococcus aureus</em> (Methicillin-resistant, MRSA)</li>
  <li><em>Klebsiella pneumoniae</em> (Carbapenem-resistant, CRKP)</li>
  <li><em>Acinetobacter baumannii</em> (Pan-drug resistant)</li>
  <li><em>Pseudomonas aeruginosa</em> (Multidrug-resistant)</li>
  <li><em>Enterobacter</em> species</li>
</ul>
<p>These bacteria employ sophisticated molecular evasion strategies: production of hydrolytic enzymes (such as New Delhi metallo-beta-lactamases, NDM-1), active multidrug efflux pump overexpression (e.g., MexAB-OprM), ribosomal target site alterations, and thick biofilm encapsulation that repels antibiotic penetration by up to a thousand-fold.</p>

<h2>2. Resurrecting Bacteriophage Therapy with Synthetic Biology</h2>
<p>With the commercial pharmaceutical pipeline for novel small-molecule antibiotics dwindling due to adverse economic incentives, translational researchers are revisiting and engineering <strong>bacteriophages</strong>—viruses that specifically target and lyse bacterial cells without harming human tissue or commensal microbiota.</p>
<p>Synthetic biology platforms now enable precision CRISPR-Cas engineered phages that actively disrupt bacterial plasmids encoding resistance genes. In landmark compassionate-use protocols authorized by the FDA, personalized bacteriophage cocktails successfully cured refractory disseminated <em>Mycobacterium abscessus</em> and <em>Pseudomonas</em> prosthetic joint infections that had resisted months of intravenous antibiotics.</p>

<h2>3. Antimicrobial Peptides (AMPs) and AI Discovery</h2>
<p>Another promising frontier lies in cationic antimicrobial peptides (AMPs). These amphipathic molecules physically disrupt bacterial cell membranes via barrel-stave or carpet mechanisms, making the emergence of resistance far less thermodynamically favorable.</p>
<p>Machine learning diffusion architectures are currently screening billions of synthetic peptide combinations, generating novel candidates with high selectivity for bacterial lipid bilayers (rich in negative phosphatidylglycerol) over zwitterionic mammalian cell membranes.</p>

<h2>4. Clinical Stewardship and One Health Principles</h2>
<p>Technological innovations alone will not avert the AMR crisis without systemic clinical antibiotic stewardship. Hospitals must mandate rapid multiplex PCR diagnostic tests to differentiate viral from bacterial infections before prescribing broad-spectrum cephalosporins or fluoroquinolones. Furthermore, global adoption of the "One Health" framework—restricting the non-therapeutic prophylactic use of medically important antibiotics in livestock agriculture—is paramount to safeguarding modern medicine.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1584308666744-24d5c474f2ae?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Laboratory petri dishes displaying antimicrobial susceptibility testing and bacterial inhibition zones",
      status: "PUBLISHED",
      publishedAt: new Date("2026-01-28T10:00:00Z"),
      readingTime: 6,
      viewsCount: 620,
      isFeatured: false,
      authorId: author3.id,
      reviewedById: author2.id,
      metaTitle: "Antimicrobial Resistance & Phage Therapy: Global Solutions",
      metaDescription: "Comprehensive analysis of multidrug-resistant ESKAPE pathogens, clinical phage therapy, synthetic antimicrobial peptides, and antimicrobial stewardship.",
      sources: JSON.stringify([
        { title: "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis", url: "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext", citation: "Murray, C. J., et al. (2022). The Lancet, 399(10325), 629–655." },
        { title: "Phage therapy: An alternative to antibiotics in the age of multidrug resistance", url: "https://www.frontiersin.org/articles/10.3389/fmicb.2021.688899/full", citation: "Lin, D. M., et al. (2021). Frontiers in Microbiology, 12, 688899." },
      ]),
      categories: { connect: [{ id: catPublicHealth.id }] },
      tags: { connect: [{ id: tagPharmacology.id }, { id: tagClinical.id }] },
    },
  });

  // Post 8: Wearable ECG & PPG
  await prisma.post.create({
    data: {
      title: "Continuous Physiological Monitoring: The Clinical Utility of Wearable ECG and Photoplethysmography",
      slug: "continuous-physiological-monitoring-wearable-ecg-ppg",
      excerpt: "Evaluating single-lead ECG smartwatches, photoplethysmography algorithms, subclinical atrial fibrillation detection, and false positive burdens.",
      content: `
<p>The ubiquity of consumer wearable devices—ranging from smartwatches and biometric rings to smart patches—has ushered in an era of continuous, real-time longitudinal cardiovascular telemetry. What was once confined to 24-hour Holter monitors or telemetry units in hospital cardiac wards is now streaming continuously from millions of wrists worldwide. However, the translation of consumer wearable data into actionable clinical cardiology demands a rigorous understanding of the underlying sensor physics, signal processing algorithms, and statistical realities of screening asymptomatic populations.</p>

<h2>1. Sensor Technologies: ECG versus Photoplethysmography (PPG)</h2>
<p>Wearable cardiovascular trackers utilize two primary sensing modalities:</p>
<ul>
  <li><strong>Photoplethysmography (PPG):</strong> Optical sensors emit green LED light (wavelength approx. 520–550 nm) into the cutaneous capillary bed, measuring changes in light absorption caused by pulsatile microvascular blood volume fluctuations. PPG algorithms detect pulse cycle intervals (tachograms) to identify irregular pulse rhythms during periods of user rest.</li>
  <li><strong>Single-Lead Electrocardiography (ECG):</strong> By touching a digital crown or chassis electrode with a finger from the opposite hand, the user closes an electrical circuit across the chest (creating a Lead I equivalent vector). The device records true cardiac depolarization and repolarization waveforms (P-QRS-T complex), allowing direct morphological assessment of atrial activity.</li>
</ul>

<h2>2. Clinical Evidence in Atrial Fibrillation Detection: The Apple Heart and Fitbit Studies</h2>
<p>Atrial fibrillation (AFib) is the most common cardiac arrhythmia and a major cause of embolic ischemic strokes. Because AFib is frequently paroxysmal and asymptomatic, early detection offers an opportunity for stroke prevention via oral anticoagulation.</p>
<p>In the landmark <em>Apple Heart Study</em> published in the <em>New England Journal of Medicine</em> (enrolling over 419,000 participants), when an irregular pulse notification was triggered, follow-up patch monitors confirmed AFib in 34% of cases. The positive predictive value for subsequent ECG patch confirmation was 0.84 for individual notifications.</p>

<h2>3. The Clinical Burden of False Positives and "Cyberchondria"</h2>
<p>While the technological achievement is extraordinary, cardiologists frequently caution against unselected mass screening of low-risk young populations:</p>
<ol>
  <li><strong>Low Pre-Test Probability:</strong> In healthy individuals under age 50 with no vascular risk factors (CHA2DS2-VASc score of 0), the prevalence of AFib is low. Screening this demographic yields high rates of false-positive alerts, causing anxiety, unnecessary clinical workups, and inappropriate anticoagulation requests.</li>
  <li><strong>Diagnostic Disclaimers:</strong> Smartwatch algorithms are FDA-cleared specifically for rhythm classification; they cannot detect myocardial ischemia, acute coronary syndromes, electrolyte disturbances, or QT prolongation.</li>
</ol>

<h2>4. The True Clinical Paradigm: High-Risk and Cryptogenic Stroke Cohorts</h2>
<p>The optimal clinical niche for wearable physiological monitoring is targeted surveillance in high-risk patient cohorts: patients following cryptogenic ischemic strokes, individuals with severe obstructive sleep apnea, post-cardiac ablation monitoring, and heart failure patients benefiting from pulmonary fluid status algorithms. In these populations, continuous biometric telemetry reliably captures actionable clinical events weeks before overt decompensation occurs.</p>
      `,
      featuredImage: "https://images.unsplash.com/photo-1508847154043-be5407fcaa5a?auto=format&fit=crop&w=1200&q=80",
      featuredImageAlt: "Modern digital smartwatch on wrist displaying high-resolution electrocardiogram waveform and pulse telemetry",
      status: "PUBLISHED",
      publishedAt: new Date("2026-01-22T17:10:00Z"),
      readingTime: 6,
      viewsCount: 890,
      isFeatured: false,
      authorId: author1.id,
      reviewedById: author2.id,
      metaTitle: "Wearable ECG & PPG in Cardiology: Clinical Evidence",
      metaDescription: "Clinical analysis of smartwatch ECG and optical PPG sensors, atrial fibrillation screening trial outcomes, and diagnostic limitations.",
      sources: JSON.stringify([
        { title: "Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation", url: "https://www.nejm.org/doi/full/10.1056/NEJMoa1901183", citation: "Perez, M. V., et al. (2019). New England Journal of Medicine, 381(20), 1909–1917." },
        { title: "Wearable devices for cardiac rhythm assessment: A clinical perspective", url: "https://www.sciencedirect.com/science/article/pii/S073510972037704X", citation: "Gawałko, M., et al. (2021). Journal of the American College of Cardiology, 78(8), 820–834." },
      ]),
      categories: { connect: [{ id: catMedTech.id }, { id: catInnovation.id }] },
      tags: { connect: [{ id: tagCardiology.id }, { id: tagClinical.id }] },
    },
  });

  // 7. Seed Real, Well-Written Default Content for All Legal & Informational Pages
  console.log("Writing comprehensive legal and informational pages...");

  // Medical Disclaimer Page
  await prisma.page.create({
    data: {
      slug: "medical-disclaimer",
      title: "Medical & Health Information Disclaimer",
      metaTitle: "Medical Disclaimer | Evidence-Based Health Editorial Policy",
      metaDescription: "Read our comprehensive medical disclaimer. All content is for educational and informational purposes only and does not constitute professional medical advice.",
      content: `
<h2>1. General Educational and Informational Purpose Only</h2>
<p>The contents of this website—including articles, text, graphics, data summaries, images, infographics, and other materials (collectively referred to as "Content")—are prepared strictly for general educational, academic, and informational purposes. The Content is designed to support, not replace, the relationship that exists between a patient and their physician or qualified healthcare provider.</p>

<p><strong>This website does not provide personal medical advice, clinical diagnosis, or individual treatment plans.</strong></p>

<h2>2. Not a Substitute for Professional Medical Advice</h2>
<p>Never disregard professional medical advice, delay seeking clinical evaluation, or discontinue prescribed pharmacotherapy or medical therapies because of something you have read on this website. If you believe you may be experiencing a medical emergency, immediately call your local emergency services (such as 911 in the United States, 999 in the United Kingdom, 112 in the European Union or India) or proceed immediately to the nearest hospital emergency room.</p>

<h2>3. No Doctor-Patient Relationship Established</h2>
<p>Accessing, browsing, submitting questions through our contact forms, or interacting with the authors, editors, or contributors of this website does not establish a doctor-patient, therapist-patient, or confidential clinical relationship. Communications through our public website or electronic forms are not privileged and are subject to the terms outlined in our Privacy Policy.</p>

<h2>4. Clinical Information and Research Accuracy</h2>
<p>While our editorial board and qualified medical contributors make every reasonable effort to ensure that the scientific information, pharmaceutical data, and clinical trial results published on this platform are accurate, up-to-date, and derived from peer-reviewed biomedical literature, medical knowledge evolves rapidly. New clinical trial findings, regulatory recalls, drug interaction notices, and updated guidelines may render certain information outdated or incomplete. We do not warrant or guarantee the completeness, efficacy, or currency of any Content published herein.</p>

<h2>5. Pharmaceutical Products, Dosages, and Off-Label Uses</h2>
<p>Mentions of specific pharmaceuticals, biologic agents, dietary supplements, off-label indications, surgical interventions, medical devices, or clinical algorithms do not constitute an endorsement, clinical recommendation, or verification of safety. Readers must consult licensed prescribers, certified pharmacists, and official package inserts for licensed indications, contraindications, boxed warnings, and proper dosing protocols.</p>

<h2>6. External Links and Citations</h2>
<p>Our articles frequently cite academic literature, governmental agencies (such as the FDA, CDC, NIH, EMA, and WHO), and peer-reviewed journals. We are not responsible for the content, privacy practices, or accuracy of third-party websites linked within our reference sections.</p>
      `,
    },
  });

  // Privacy Policy Page
  await prisma.page.create({
    data: {
      slug: "privacy-policy",
      title: "Privacy Policy",
      metaTitle: "Privacy Policy | GDPR, CCPA, and Google AdSense Compliance",
      metaDescription: "Our Privacy Policy outlines how we collect, protect, and process user data, cookies, Google AdSense advertising, analytics, and your privacy rights under GDPR, CCPA, and DPDP.",
      content: `
<p><em>Last updated: February 2026. This privacy policy applies to all visitors, readers, and registered users of this publication.</em></p>

<h2>1. Introduction &amp; Commitment to Privacy</h2>
<p>We respect your privacy and are committed to protecting your personal data in full compliance with global privacy regulations, including the European Union General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA/CPRA), the UK Data Protection Act, and the India Digital Personal Data Protection Act (DPDP).</p>

<h2>2. Information We Collect</h2>
<h3>A. Information You Voluntarily Provide</h3>
<ul>
  <li><strong>Contact Form Inquiries:</strong> When you send a message through our Contact Us page, we collect your name, email address, subject, and the message content solely to respond to your inquiry.</li>
  <li><strong>Newsletter Subscriptions:</strong> If you voluntarily subscribe to our health updates, we collect your email address. You may unsubscribe at any time via the one-click unsubscribe link in any email.</li>
</ul>

<h3>B. Information Collected Automatically</h3>
<ul>
  <li><strong>Log Data and Device Identifiers:</strong> When you browse our site, our servers automatically log non-personally identifiable technical information, such as IP addresses (anonymized where required), browser type, referring URLs, operating system, and timestamp data.</li>
  <li><strong>Aggregated Usage Analytics:</strong> We use Google Analytics to analyze traffic patterns and content popularity. We configure Google Analytics to anonymize IP addresses and minimize data retention.</li>
</ul>

<h2>3. Cookies, Web Beacons, and Tracking Technologies</h2>
<p>A cookie is a small text file stored on your device by your web browser. We use essential cookies (necessary for site security and navigation) and non-essential cookies (for analytics and advertising preferences). You can manage or disable non-essential cookies at any time via our Cookie Consent Banner or your browser settings.</p>

<h2>4. Third-Party Advertising and Google AdSense</h2>
<p>We partner with third-party advertising vendors, including Google AdSense, to display advertisements when you visit our website. These companies may use cookies, device identifiers, and similar technologies to serve ads based on your prior visits to this and other websites across the Internet.</p>
<ul>
  <li><strong>Google's DoubleClick Cookie:</strong> Google uses the DoubleClick cookie to enable it and its partners to serve personalized or contextual ads based on users' visits to our site and/or other sites on the Internet.</li>
  <li><strong>Opt-Out of Personalized Advertising:</strong> You may opt out of personalized advertising by visiting <a href="https://adssettings.google.com" target="_blank" rel="noopener noreferrer">Google Ads Settings</a>. Alternatively, you can opt out of third-party vendors' use of cookies for personalized advertising by visiting <a href="https://www.aboutads.info/choices/" target="_blank" rel="noopener noreferrer">AboutAds.info</a>.</li>
  <li>Where required by law (e.g., in the EEA, UK, and California), advertising cookies and personalized ad scripts load only after you have granted explicit consent.</li>
</ul>

<h2>5. Data Retention and Security</h2>
<p>We implement industry-standard encryption, SSL/TLS protocols, strict access controls, and hashed password security. Contact form messages and subscriber emails are retained only for as long as necessary to fulfill the requested communication or service.</p>

<h2>6. Your Legal Privacy Rights</h2>
<p>Depending on your jurisdiction, you have the right to:</p>
<ul>
  <li><strong>Access:</strong> Request a copy of the personal data we hold about you.</li>
  <li><strong>Rectification:</strong> Request correction of inaccurate or incomplete information.</li>
  <li><strong>Erasure ("Right to be Forgotten"):</strong> Request deletion of your personal contact or subscription records.</li>
  <li><strong>Withdraw Consent:</strong> Revoke consent for newsletter emails or non-essential cookies at any time without penalty.</li>
</ul>
<p>To exercise any of these rights, please contact our Data Protection Officer at <code>privacy@sitename.com</code>.</p>
      `,
    },
  });

  // Terms & Conditions Page
  await prisma.page.create({
    data: {
      slug: "terms",
      title: "Terms and Conditions of Use",
      metaTitle: "Terms & Conditions | User Agreement & Legal Guidelines",
      metaDescription: "Review the Terms and Conditions governing your access and use of our healthcare publication, intellectual property rights, and user conduct.",
      content: `
<h2>1. Acceptance of Terms</h2>
<p>By accessing and reading this website, you agree to be bound by these Terms and Conditions of Use, all applicable laws and regulations, and agree that you are responsible for compliance with any applicable local laws. If you do not agree with any of these terms, you are prohibited from using or accessing this site.</p>

<h2>2. Intellectual Property Rights</h2>
<p>All original articles, editorial analyses, diagrams, branding logos, and custom software code published on this site are the intellectual property of this publication and its contributors, protected by international copyright, trademark, and intellectual property conventions. You may quote short excerpts (up to 150 words) for non-commercial educational purposes, provided clear attribution and a direct hyperlink back to the original source article are included.</p>

<h2>3. User Conduct and Prohibited Activities</h2>
<p>You agree not to:</p>
<ul>
  <li>Use automated scrapers, crawlers, or harvesting tools to extract content for commercial syndication without prior written permission.</li>
  <li>Transmit unsolicited promotional materials, spam, or malicious payloads through our contact forms or subscription endpoints.</li>
  <li>Attempt to bypass, disable, or tamper with security measures, authentication portals, or ad verification protocols.</li>
</ul>

<h2>4. Limitation of Liability</h2>
<p>In no event shall this publication, its editorial board, authors, clinical reviewers, or affiliates be liable for any direct, indirect, incidental, consequential, or punitive damages arising out of your access to, or use of, any Content, opinions, or products reviewed on this website.</p>
      `,
    },
  });

  // Cookie Policy Page
  await prisma.page.create({
    data: {
      slug: "cookie-policy",
      title: "Cookie Policy",
      metaTitle: "Cookie Policy | How We Use Cookies & Advertising Tags",
      metaDescription: "Learn how our website utilizes essential, performance, analytics, and Google AdSense advertising cookies, and how you can manage your preferences.",
      content: `
<h2>1. What Are Cookies?</h2>
<p>Cookies are small data files placed on your computer or mobile device when you visit a website. They are widely used by online publishers to facilitate site navigation, protect user sessions, remember preferences, and analyze user engagement.</p>

<h2>2. Categories of Cookies We Use</h2>
<ul>
  <li><strong>Strictly Necessary Cookies:</strong> Essential for website operation, session security, and routing. These cannot be switched off.</li>
  <li><strong>Functional Cookies:</strong> Remember your interface preferences, such as Dark Mode / Light Mode and cookie preference selections.</li>
  <li><strong>Performance &amp; Analytics Cookies:</strong> Allow us to measure site visits and traffic sources via Google Analytics to assess article popularity and reader retention. Data collected is aggregated and anonymized.</li>
  <li><strong>Advertising &amp; Targeting Cookies:</strong> Placed by third-party ad networks (such as Google AdSense) to serve advertisements relevant to your interests and prevent the same ad from reappearing continuously.</li>
</ul>

<h2>3. How Can You Control Cookies?</h2>
<p>You have the right to decide whether to accept or reject non-essential cookies. You can exercise your preferences through our Cookie Consent Banner upon visiting our site, or manage cookie settings directly within your web browser settings (Chrome, Firefox, Safari, Edge).</p>
      `,
    },
  });

  // Advertising Disclosure Page
  await prisma.page.create({
    data: {
      slug: "advertising-disclosure",
      title: "Advertising & Affiliate Disclosure",
      metaTitle: "Advertising & Affiliate Disclosure | Transparent Publisher Standards",
      metaDescription: "Our transparent advertising policy explains how advertisements and affiliate partnerships are clearly demarcated from independent medical editorial content.",
      content: `
<h2>1. Commitment to Editorial Independence</h2>
<p>Our fundamental editorial priority is delivering rigorous, evidence-based healthcare information you can trust. To finance our independent journalistic operations, server infrastructure, and medical peer-review process, we display digital advertisements and may occasionally participate in verified affiliate marketing programs.</p>

<p><strong>Under no circumstances does advertising revenue influence our editorial judgment, article selection, medical reviews, or scientific conclusions.</strong></p>

<h2>2. Google AdSense and Third-Party Display Advertising</h2>
<p>Display advertisements on our website are served via Google AdSense and reputable programmatic advertising exchanges. These advertisements are clearly demarcated with "Advertisement" or "Sponsored" labels. We strictly forbid deceptive ad placements, pop-unders, auto-playing video audio, or deceptive layouts that disguise advertising as clinical content.</p>

<h2>3. Prohibited Advertising Categories</h2>
<p>In accordance with Google AdSense healthcare publisher policies and our internal clinical code of ethics, we do not accept advertisements for:</p>
<ul>
  <li>Unapproved pharmaceutical compounds, non-prescription opioids, or illicit substances.</li>
  <li>Miracle weight-loss cures, unscientific cancer treatments, or unsubstantiated detox formulas.</li>
  <li>Predatory healthcare financing or deceptive clinical trials.</li>
</ul>

<h2>4. Sponsored Content and Affiliate Links</h2>
<p>If we ever publish sponsored content or incorporate affiliate links to medical textbooks, diagnostic tools, or wellness products, the article will clearly feature a prominent disclosure statement at the very top of the page. If you purchase through an affiliate link, we may earn a small commission at zero additional cost to you.</p>
      `,
    },
  });

  // Editorial Policy Page
  await prisma.page.create({
    data: {
      slug: "editorial-policy",
      title: "Editorial Policy & Sourcing Standards",
      metaTitle: "Editorial Policy | Fact-Checking, Clinical Review, and Sourcing Standards",
      metaDescription: "Discover how our healthcare publication researches, fact-checks, medically reviews, and routinely updates health content for scientific accuracy.",
      content: `
<h2>1. Our Editorial Mission</h2>
<p>In an era of rampant health misinformation and algorithmically generated content, our mission is to provide an authoritative beacon of clinical clarity. We publish thoroughly researched, evidence-based articles that decipher complex biomedical breakthroughs for patients, clinicians, and health technology innovators.</p>

<h2>2. Clinical Review Board (E-E-A-T Framework)</h2>
<p>Every medical article published on our platform undergoes a rigorous two-tier review process:</p>
<ol>
  <li><strong>Expert Authorship:</strong> Articles are written by credentialed healthcare professionals, biomedical researchers, or experienced science journalists with formal scientific backgrounds.</li>
  <li><strong>Clinical Peer Review:</strong> Before publication, articles touching on clinical diagnostics, pharmacotherapy, or pathology are reviewed by a licensed physician (MD/DO) or subject specialist (PharmD, PhD) to verify biological accuracy and safety. Articles display the clinical reviewer's name and credentials prominently beneath the title.</li>
</ol>

<h2>3. Sourcing and Scientific Evidence Standards</h2>
<p>We do not rely on second-hand reporting or unverified social media claims. Our writers are mandated to cite primary scientific literature from authoritative sources:</p>
<ul>
  <li>Peer-reviewed biomedical journals (e.g., <em>The New England Journal of Medicine</em>, <em>The Lancet</em>, <em>Nature Medicine</em>, <em>JAMA</em>).</li>
  <li>Governmental health regulatory bodies (FDA, EMA, CDC, NIH, WHO).</li>
  <li>Official clinical practice guidelines issued by recognized medical societies (AHA, ACC, ASCO, ADA, AMA).</li>
</ul>
<p>Every article features a designated "Sources &amp; References" section at the end of the text with direct DOI links.</p>

<h2>4. Corrections and Periodic Content Audits</h2>
<p>Clinical science is dynamic. We perform regular audits of our published archives. When clinical trials report new safety signals, FDA advisories are issued, or diagnostic criteria are updated, our team updates the article content and refreshes the "Last Updated" timestamp. If a factual error is identified, we correct it promptly and transparently.</p>
      `,
    },
  });

  // About Us Page
  await prisma.page.create({
    data: {
      slug: "about",
      title: "About Our Healthcare Publication",
      metaTitle: "About Us | Dedicated to Evidence-Based Clinical Insights",
      metaDescription: "Learn about our healthcare publication, our multidisciplinary editorial board of physicians and scientists, and our commitment to medical truth.",
      content: `
<h2>1. Who We Are</h2>
<p>Welcome to our publication—a premier, evidence-driven digital healthcare and medical technology platform. We were founded by a multidisciplinary consortium of board-certified clinicians, biomedical engineers, and science communicators united by a shared realization: the public deserves health journalism that does not compromise between scientific accuracy and clear, accessible prose.</p>

<h2>2. Why We Exist</h2>
<p>The contemporary health media ecosystem is saturated with sensationalized headlines, unscientific fad diets, and confusing jargon. We exist to bridge the gap between academic biomedical literature and everyday healthcare decisions. Whether analyzing how artificial intelligence assists stroke triage, evaluating novel mRNA cancer immunotherapies, or exploring circadian rhythm biology, our commitment is grounded in rigorous scientific evidence.</p>

<h2>3. Our Multidisciplinary Team</h2>
<ul>
  <li><strong>Dr. Sarah Jenkins, MD, FACC:</strong> Chief Medical Officer and Board-Certified Cardiologist with extensive clinical trial experience in cardiovascular prevention and hemodynamic technologies.</li>
  <li><strong>Dr. Marcus Chen, PhD:</strong> Senior Technology Editor and Biomedical Engineer specializing in computational pathology, machine learning algorithms, and wearable physiological biosensors.</li>
  <li><strong>Dr. Elena Rostova, PharmD, BCPS:</strong> Clinical Pharmacotherapy Specialist focusing on precision oncology, targeted biologic molecules, and gut microbiome pharmacodynamics.</li>
</ul>

<h2>4. Our Core Values</h2>
<ol>
  <li><strong>Scientific Integrity:</strong> Every claim must be tethered to reproducible, peer-reviewed biomedical research.</li>
  <li><strong>Patient Safety First:</strong> We emphasize preventative medicine while upholding clear disclaimers that digital content never replaces direct consultation with your personal physician.</li>
  <li><strong>Radical Transparency:</strong> All potential conflicts of interest, advertising affiliations, and author credentials are displayed openly.</li>
</ol>
      `,
    },
  });

  // 8. Site Settings
  console.log("Configuring default site settings...");
  const defaultSettings = [
    { key: "siteName", value: "[SITE NAME]" },
    { key: "tagline", value: "Evidence-Based Medical Innovations, Clinical Insights & Wellness Science" },
    { key: "description", value: "A premier peer-reviewed health publication delivering evidence-backed articles on healthcare technology, medical breakthroughs, clinical therapeutics, nutrition, and public health." },
    { key: "adsEnabled", value: "true" },
    { key: "adsensePublisherId", value: "" },
    { key: "googleAnalyticsId", value: "" },
    { key: "adsTxtContent", value: "google.com, pub-XXXXXXXXXXXXXXXX, DIRECT, f08c47fec0942fa0" },
    {
      key: "adSlotsConfig",
      value: JSON.stringify({
        headerBanner: true,
        inArticle: true,
        sidebar: true,
        endOfPost: true,
        stickyMobileFooter: true,
      }),
    },
    {
      key: "socialLinks",
      value: JSON.stringify({
        twitter: "https://twitter.com/sitename",
        linkedin: "https://linkedin.com/company/sitename",
        facebook: "https://facebook.com/sitename",
        youtube: "https://youtube.com/sitename",
      }),
    },
    { key: "footerText", value: `© ${new Date().getFullYear()} [SITE NAME]. All rights reserved. Content is for educational purposes only.` },
  ];

  for (const s of defaultSettings) {
    await prisma.siteSetting.create({ data: s });
  }

  // 9. Demo Subscriber & Contact Message
  await prisma.subscriber.create({
    data: {
      email: "reader.preview@example.com",
      status: "ACTIVE",
      source: "homepage_newsletter",
    },
  });

  await prisma.contactMessage.create({
    data: {
      name: "Prof. Alexander Vance",
      email: "a.vance@university-med.edu",
      subject: "Inquiry Regarding Citation in Clinical AI Article",
      message: "Hello Editorial Team, I thoroughly enjoyed your comprehensive piece on AI in healthcare. Would your team be open to collaborating on a clinical prospective study analysis on sepsis biomarkers?",
      isRead: false,
      isSpam: false,
    },
  });

  console.log("✅ Seeding completed successfully!");
}

main()
  .catch((e) => {
    console.error("❌ Error seeding database:", e);
    process.exit(1);
  })
  .finally(async () => {
    await prisma.$disconnect();
  });
